Clinical Trials Browser

Phase 1 × Prostate Adenocarcinoma × 90 days × Clear all

NCT06044857 2026-04-14

PSMA PET Response Guided SabR in High Risk Pca

Phase 1 Recruiting

Prostate Adenocarcinoma